Hematech, LLC

$3M Congressional appropriation to support antibody development programs

Published in Health Insurance Law Weekly, August 22nd, 2004

Hematech, LLC, announced that the House and Senate conference committee on the FY 2005 Defense Department Appropriations bill has included $3 million to support Hematech's antibody development programs.

The funding will be administered by the Army's Joint Vaccine Acquisition Program (JVAP). This is the second consecutive year that funding was included in the DoD's appropriation bill at the request of South Dakota's Senator, Tom Daschle.

Hematech is developing a large-scale bovine production system that will enable the company to rapidly produce fully human polyclonal antibodies. These antibodies can be used for a wide variety of therapeutic...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly

Source: Health Insurance Law Weekly (2004-08-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry